Advertisement

Burlington-based medical device firm InfraReDx Inc. has completed a $21 million equity funding, intended for the commercial launch of its LipiScan IVUS Coronary Imaging System.

The financing was backed by both new and returning investors, though the company names only Sanderling Ventures.

SOURCE

Advertisement
Advertisement